CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Exercise or conversion Chief Medical Officer acquired 15,117 shares (option exercise)
- 4 Grant or award President and CEO acquired 1,979 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,289 shares (grant or award)
- 4 Open-market sale Director sold 22,086 shares at $11.18 ($247,008)
- 4 Open-market sale Director sold 22,086 shares at $11.18 ($247,008)
- 4 Open-market sale Director sold 38,459 shares at an average $11.56 ($444,404)
- 4 Open-market sale Director sold 38,459 shares at an average $11.56 ($444,404)
- 4 Open-market sale Director sold 42,550 shares at $11.71 ($498,078)
- 4 Open-market sale Director sold 42,550 shares at $11.71 ($498,078)
- 4 Open-market sale Director sold 45,324 shares at an average $11.61 ($526,088)
- 4 Open-market sale Director sold 45,324 shares at an average $11.61 ($526,088)
- 4 Open-market sale Director sold 51,581 shares at an average $11.50 ($593,428)
- 4 Open-market sale Director sold 51,581 shares at an average $11.50 ($593,428)
- 4 Open-market sale Director sold 86,270 shares at an average $11.16 ($962,907)
- 4 Open-market sale Director sold 86,270 shares at an average $11.16 ($962,907)
- 4 Open-market sale Director sold 13,730 shares at $11.03 ($151,498)
- 4 Open-market sale Director sold 13,730 shares at $11.03 ($151,498)
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- 4 Other disposition Director disposed of 0 shares (other)
- 4 Other disposition Director disposed of 300,000 shares (other)
Page 17 of 20 · 400 filings